Lobo
Payments companies reported to CMS as associated with Lobo. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Lobo, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Lobo
These are the largest totals companies reported as associated with Lobo. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Nima Kokabi | Atlanta, GA | Vascular & Interventional Radiology | $206,709.10 |
| Devaraj Pyne | Rochester, NY | Vascular & Interventional Radiology | $33,798.13 |
| Daniel Levi | Los Angeles, CA | Pediatric Cardiology | $26,275.00 |
| Harris Chengazi | Williamsville, NY | Vascular & Interventional Radiology | $14,763.61 |
| Brian Funaki | Chicago, IL | Diagnostic Radiology | $12,497.42 |
| Johannes Du Pisanie | Chapel Hill, NC | Vascular & Interventional Radiology | $9,659.51 |
| Charles Martin | Cleveland, OH | Vascular & Interventional Radiology | $8,543.39 |
| Omar Chohan | Williamsville, NY | Vascular & Interventional Radiology | $5,031.79 |
| Richard Grinstead | Florence, SC | Vascular & Interventional Radiology | $4,437.18 |
| Tomas Appleton Figueira | Worcester, MA | Vascular & Interventional Radiology | $2,641.54 |
Prescribed Lobo?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.